Preclinical neuropharmacological effects of Centella asiatica-derived asiaticoside and madecassoside in Alzheimer's disease
Authors:
- Narudol TeerapattarakanNTNarudol Teerapattarakan
- Utcharaporn KamsrijaiUKUtcharaporn Kamsrijai
- Adchara JanyouAJAdchara Janyou
- Phateep HankittichaiPhateep Hankittichai
- Shisanupong AnukanonSAShisanupong Anukanon
- Thaneeya HawisetTHThaneeya Hawiset
- Utthapon IssaraUtthapon Issara
- 12 March 2025
- journal article
- Published by Elsevier in South African Journal of Botany
- Vol. 180, 171-184
Abstract
No abstract availableThis publication has 89 references indexed in Scilit:
- Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugsAgeing Research Reviews, 2023
- Ginkgolides and Huperzine A for complementary treatment of Alzheimer's diseaseIUBMB Life, 2022
- Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s diseaseInflammopharmacology, 2021
- Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease2020
- LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer’s DiseaseMolecular Neurobiology, 2019
- Lysosomal cathepsins and their regulation in aging and neurodegenerationAgeing Research Reviews, 2016
- Endothelial Dysfunction and Amyloid-β-Induced Neurovascular AlterationsCellular and Molecular Neurobiology, 2015
- Mitochondrial permeability transition pore is a potential drug target for neurodegenerationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Asiaticoside-induced elevation of antioxidant levels in healing woundsPhytotherapy Research, 1999
- Determination of biologically active constituents in Centella asiaticaJournal of Chromatography A, 1996